Get the clinical insights most relevant to you and your patients
You see a broad list of patient types and treat a wide range of conditions, requiring information on a case-by-case, patient-by-patient basis. That’s why Quest Diagnostics offers Primary Insights, a site for healthcare professionals, their practices, and their staff. Find the insights you need, when you need them, for improved patient care. Quest provides clinical insights and testing information that can help you support organizational guidelines for all patient, visit, and condition types.
Non-Small Cell Lung Cancer: Laboratory Testing for Diagnosis and Management
This article discusses diagnosis of NSCLC and the importance of biomarker testing for determining prognosis and guiding therapy.
Breast Cancer: Screening and Early Diagnosis
This article will discuss breast cancer screening, diagnosis, and how diagnosis at an early stage can improve outcomes. Although this article uses the terms woman, female, man, and male to reflect language in source materials, healthcare professionals should also consider the needs of transgender and gender-diverse individuals in terms of counseling, screening, and treatment.
Chronic Lymphocytic Leukemia: Diagnosis and Prognostic Markers
This article discusses CLL and related diseases, including CLL symptoms, diagnosis, prognostic markers, staging, and treatment.
Women and Cardiovascular Disease: Risk Assessment
This article discusses CVD, traditional risk factors, risk-enhancing factors, and guideline recommendations for assessing CVD risk in women.
Tuberculosis: Laboratory Support of Screening and Diagnosis
This article discusses TB, risk factors, and screening guidelines. It also discusses the traditional tuberculin skin test (TST) and more recently developed TB blood tests, as well as the indications for each type of test.
Dementia and Alzheimer’s Disease: Laboratory Testing for Early Detection
This article will discuss MCI and dementia, with a focus on Alzheimer’s disease and laboratory testing to assist diagnosis. Also discussed is the importance of early diagnosis, prevention, and management. Finally, we discuss controversies related to screening for MCI, dementia, and Alzheimer’s disease.
Malignant Melanoma: Diagnosis, Laboratory Testing, and Management
This article will discuss the causes, risk factors, diagnosis, classification, management, and prevention of melanoma, including the importance of early detection.
Universal Chlamydia and Gonorrhea Screening in Young Women
This article will discuss the importance of universal screening for chlamydia and gonorrhea in sexually active females <25 years old, including the effectiveness of opt-out testing. Also discussed are screening guidelines, barriers to screening, and how healthcare providers can better communicate with patients to encourage appropriate screening.
New Guidelines for Assessing Chronic Kidney Disease
This article will discuss CKD, the use of creatinine and cystatin C for calculating eGFR, and the race-neutral CKD-epidemiology collaboration (EPI) 2021 creatinine-based equation for calculating eGFR.
Apolipoprotein B and Cardiovascular Risk
This article will discuss ApoB in the context of ASCVD and the inclusion of ApoB in guidelines for risk stratification.
Insulin Resistance and the Evolution of Type 2 Diabetes
This article reviews how insulin resistance contributes to the evolution of type 2 DM, a global health issue. Risk factors and laboratory testing that help identify individuals with insulin resistance are discussed, as well as lifestyle changes that can treat or prevent the development of DM and reduce the risk of other serious conditions associated with insulin resistance. Also reviewed are DM screening recommendations, diagnosis, management, complications, and comorbidities.
Breast Cancer: Current Disparities in Care
This article will discuss breast cancer, including how genetic testing can be used to assess risk for hereditary breast cancer. Disparities in screening, treatment, mortality, genetic counseling, and testing for minority patients will be discussed, as well as potential solutions.
Cardiometabolic Disease
This article will discuss how the interplay of various bodily systems affects the risk and development of cardiometabolic diseases. It will also discuss new paradigms of management and how the laboratory can help identify patients with, or at risk of, one or more cardiometabolic disorders.
Multiple Myeloma: Laboratory Support of Diagnosis and Management
This article reviews the epidemiology, pathophysiology, and presentation of multiple myeloma and its premalignant stages. It also discusses the important role the laboratory plays in the diagnosis and management of multiple myeloma.
Hepatitis B: Laboratory Support of Diagnosis and Management
This article discusses the epidemiology, disease course, and prevention of hepatitis B, as well as the laboratory’s role in screening, diagnosis, and management.
Lyme Disease: Laboratory Testing for Diagnosis
This article discusses Lyme disease, its complications, and the importance of early diagnosis, laboratory testing, and treatment.
Melanoma: Early Detection and Challenges During the Pandemic
This article will discuss melanoma and the importance of early detection. Challenges, approaches, and recommendations for screening and treatment during the pandemic will also be discussed.
Transplantation: Laboratory Testing for Screening and Monitoring Infectious Diseases
This article will discuss the importance of laboratory testing for patients who donate and receive transplants, with a focus on screening and monitoring for infectious diseases.
Colorectal Cancer Screening During the Pandemic
This article will discuss CRC, the effect the COVID-19 pandemic on screening and diagnosis, and how the laboratory can help provide options for safe CRC screening during the pandemic.
Chronic Kidney Disease: Laboratory Support of Diagnosis and Management
This article will discuss CKD, its risk factors and comorbidities, and how the laboratory can assist in diagnosis and management.
Neurological Diseases and COVID-19
This article will discuss current knowledge of the association of COVID-19 with neurological disease and how the laboratory can help in the diagnosis and management of patients with COVID-19 and neurological complications.
Cardiovascular Disease, Influenza, and COVID-19
This article will discuss associations of cardiovascular disease risk and outcomes with seasonal influenza, as well as emerging information on associations with COVID-19. Laboratory testing is important for recognizing potential cardiovascular effects of these illnesses.
Celiac Disease: Laboratory Support for Diagnosis
This article will discuss celiac disease and the role of laboratory testing in diagnosis.
Hepatitis C—New Guidelines Expand Screening Recommendations
This article will discuss HCV infection and new screening guidelines. The guidelines reflect the changing demographics of high-risk populations, which have been influenced by the opioid epidemic in recent years.
Hereditary Breast Cancer
This article will discuss hereditary breast cancer, and how genetic testing can be used to assess risk.
Autoimmune Rheumatic Diseases: Diagnosis and Management
This article will review ARDs and the importance of early and accurate diagnosis. It will discuss the importance of laboratory testing for autoantibodies and how antibody panels can help to rule in or rule out common autoimmune diseases.
Subscribe to Primary Insights
Get the clinical insights most relevant to you and your patients, from the lab committed to knowing.